Oritavancin
Product Description
BrightGene Bio-Medical Technology Co.,Ltd.
-
CN -
2015On CPHI since
Specifications
BrightGene Bio-Medical Technology Co.,Ltd.
-
CN
-
2015On CPHI since
More Products from BrightGene Bio-Medical Technology Co.,Ltd. (49)
-
Product POB
• Status: DMF Ready • Usage: For Posaconazole -
Product POA
• Status: DMF Ready • Usage: For Posaconazole -
Product MFA
• Status: DMF No.:030028 • Usage: For Micafungin -
Product ET1
• Status: DMF No.: 026257 • Usage: For Entecavir -
Product FSC
• Status: DMF No.: 028552 • Usage: For Fondaparinux Sodium -
Product Dydrogesterone
• Status: Pilot • Patent Expiration: Off-patent • Usage: Progestogens -
Product Pimecrolimus
• Status: DMF No.: 030090 • Patent Expiration: Off-patent • Usage: Immunosuppressant -
Product Everolimus（without BHT）
• Status: MF No.: 230MF10023 • Patent Expiration: Off-patent • Usage: Oncology -
Product Midostaurin
• Status: Validated • Patent Expiration: Off-patent • Usage: Oncology -
Product Fondaparinux Sodium
• Status: DMF No. :030767 • Patent Expiration: Off-patent • Usage:Anticoagulant -
Product Anidulafungin
Status:
DMF No.: 032010
ASMF Approved
Patent Expiration: Off-patentUsage: Antifungal -
Product Argatroban Monohydrate
• Status: MF No.: 230MF10028; USDMF to be filed in Q4,2020 • Patent Expiration: Off-patent • Usage:Anticoagulant
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance